Cypherpunk Technologies Inc.
CYPH
Get informed when a big investor buys or sells
+ FollowMarket Cap$31.86M
Close$
Share Statistics
| Market cap | $31.86 Million |
|---|---|
| Enterprise Value | $24.37 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 26.49% |
|---|---|
| Return on Assets | 25.81% |
| Return on Invested Capital | -28.72% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 116.59 |
| Enterprise Value to EBIT | -0.6 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.03
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$0.02
Average shareholder expectationRevenue Estimate
$11.70 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Leap Therapeutics Inc
6 employees
CEO: Douglas E. Onsi Cypherpunk Technologies Inc. is a privacy-focused technology company that combines a digital asset treasury strategy centered on Zcash (ZEC) with the development of novel cancer therapies through its subsidiary. The company's mission is ...